Gene editing lowered blood level cholesterol and triglycerides in monkeys

27-Jun-2020
KEY POINTS FROM ARTICLE:

Scientists have disabled two genes in monkeys that raise the risk for heart disease.
One is PCSK9, which helps regulate levels of LDL cholesterol.
The other is ANGPTL3, part of the system regulating triglyceride, a type of blood fat.
Both are active in liver, which is where cholesterol and triglycerides are produced.
People who inherit mutations that destroyed the genes’ function do not get heart disease.
The medicine consists of two pieces of RNA — a gene editor and a tiny guide.
Not only did the system work in 13 monkeys, but it appeared that every liver cell was edited.
The monkeys’ LDL levels dropped by 59 percent within two weeks.
The ANGPTL3 gene editing led to a 64 percent decline in triglyceride levels.
First study to use the pencil-and-eraser type gene editing in primates for a very common disease.
But much too soon to say if it will be safe and long-lasting.
Research from Verve Therapeutics; not yet been peer-reviewed or published.

Could prevent not only the complications but the heart disease per se in the future

Mentioned in this article:

Academia Broad Institute of MIT and Harvard - Collaborative organization that brings academics of various disciplines in the scientific community together

Academic Deepak Srivastava - Professor in Pediatrics

Academia Gladstone Institutes - Nonprofit life science research organization

Academic Jennifer Doudna - Professor of Biomedical Science

Health Organisation Massachusetts General Hospital (MGH)

Academic Michael Davidson - Professor, Director of the Lipid Clinic, The University of Chicago

Academic Sekar Kathiresan - Physician scientist, human geneticist and professor at Harvard Medical School.

Academia The University of Chicago - Public Research university.

Academia University of California, Berkeley

Company Verve Therapeutics - Biotechnology company

Read full article on New York Times website
More Heart Disease information, news and resources
More Gene Therapy information, news and resources